Winslow Garrett
SEC CIK 1803773 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMRA | Damora Therapeutics, Inc. | GC | 2,289 | $4,960 | $16.3K | 9 | 2021-12-03 | 2026-07-06 |
Most active insiders at DMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schambye Hans T. | CEO, Dir | — | $15.0K |
| 2 | Winslow Garrett | GC | — | $12.8K |
| 3 | Firmani Lori | CFO | — | $2,890 |
| 4 | Sattarzadeh Sherwin | COO | — | — |
| 5 | Bruno Julianne | Dir | — | — |
| 6 | Hewes L. Becker | Chief Medical Off | — | — |
| 7 | Fairmount Healthcare Fund II L.P. | 10% | — | — |
| 8 | Jarrett Jennifer | See Remarks, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-07 20:00 | 2026-07-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | M - OptEx | — | +680 | 2,534 | +37% | — |
| D | 2026-07-07 20:00 | 2026-07-06 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | S - Sale+OE | $29.98 | -245 | 2,289 | -10% | -$7,345 |
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | S - Sale+OE | $21.38 | -255 | 1,854 | -12% | -$5,452 |
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | M - OptEx | — | +680 | 2,109 | +48% | — |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | M - OptEx | — | +680 | 1,689 | +67% | — |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | S - Sale+OE | $3.39 | -260 | 1,429 | -15% | -$881.40 |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | M - OptEx | — | +1,320 | 1,480 | +825% | — |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | S - Sale+OE | $5.60 | -471 | 1,009 | -32% | -$2,638 |
| 2021-12-06 | 2021-12-03 | DMRA | Damora Therapeutics, Inc. | Winslow Garrett | GC | P - Purchase | $2.48 | +2,000 | 4,000 | +100% | +$4,960 |
Purchase Sale Sale after option exercise All abbreviations